Transplant Biomedicals, an IDIBAPS spin-off created in 2014 by researchers from IDIBAPS -Dr. Carmen Peralta, Dr. Jordi Gracia-Sancho and Dr. Anna Novials-, has closed a financing round of 1.5 million euros led by Kereon Partners and in which Caixa Capital Risc and other private investors have also participated. The funds will be used to accelerate the development and marketing of innovative medical device for preservation and transport of abdominal and thoracic organs for transplantation.
Physicians from Hospital Clinic and IDIBAPS awarded with the COMB Professional Excellence Award 2015
Yesterday the Professional Excellence Awards 2015 were awarded by the Col·legi Oficial de Metges de Barcelona (COMB) to physicians in recognition to their career. In the present edition, six professionals working at Hospital Clínic and IDIBAPS have been awarded.
On October 21 the new IDIBAPS Current Research Information System (CRIS) was introduced in a participatory-briefing session held in the Esteve auditorium, at which over 100 people attended. During the presentation, held in the framework of the International Open Access Week 2015, it was announced that in September this IDIBAPS tool obtained the CVN-FECYT Certification.
The TV3 Telethon Foundation hosted yesterday evening a ceremony to present the projects selected to be funded with the 11.4 million euros collected in the past edition dedicated to heart diseases. 70 research teams, coordinated with either Spanish and international teams, will develop the 43 selected projects over the next three years. Nine of the chosen projects correspond to researchers from Hospital Clínic and IDIBAPS. IDIBAPS becomes the institution with the greater number of projects funded and coordinated in this edition. The event was held at the Academy of Medical Sciences and Health of Catalonia and the Balearic Islands and was widely attended by representatives of the scientific community.
IDIBAPS and the IrsiCaixa AIDS Research Institute participate in the European AIDS Vaccine Initiative (EAVI2020), a project to to accelerate the search for an effective HIV vaccine. This initiative, that is part of the European Comission framework programme for research and innovation (Horizon2020), brings together leading HIV researchers from public organisations and biotech companies from across Europe, Australia, Canada and the USA. IrsiCaixa and IDIBAPS are members of this consortium in which participate 22 institutions. Dr. Joan Joseph, researcher at the Infectious Diseases and AIDS IDIBAPS team led by Dr. Josep M. Gatell, will coordinate the project conducted at IDIBAPS over the next 5 years. At IrsiCaixa, an institute led by Dr. Bonaventura Clotet, this project will be coordinated by Dr. Christian Brander, head of the Host Cellullar and Genetic Immunity group and member of the consortium’s steering comitee. The other spanish participant in the consortium is the Instituto de Salud Carlos III.